“crispr-cas9” Archives

in
Entry Author Date Location
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes 06/11/20 Boston
FDA Clinical Hold Stops LogicBio’s Gene Editing Study Before It Starts 02/10/20 Boston
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More 12/06/19 National
A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns 12/03/19 National
Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugs 09/27/19 Boston
Challenging CRISPR, Trucode Raises $34M for New Gene-Editing System 09/10/19 San Francisco
Locana, Fueled With $55M, Looks to Develop Fixes for Faulty RNA 06/21/19 San Diego
Verve Has Top Cardio-Geneticist, $58.5M to Aim CRISPR at Heart Attacks 05/07/19 Boston
New CRISPR Fight: Old Friends Intellia, Caribou in License Dispute 02/06/19 San Francisco
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More 01/25/19 National
“JK Told Me He Was Planning This”: A CRISPR Baby Q&A with Matt Porteus 12/04/18 National
Bio Roundup: CRISPR Babies, Blood Diseases, Big Cancer Nod & More 11/30/18 National
Under Fire, He Jiankui Says He’s “Proud” to Help Make CRISPR’d Babies 11/28/18 National
Bio Roundup: Depression Drug Dashed, Peek at ASH, CRISPR Worry & More 11/02/18 National
CRISPR Therapeutics, Vertex Get FDA Green Light for Sickle Cell Test 10/10/18 Boston
With CRISPR’s Help, KSQ Touts 13 Cancer Drugs and Bags Another $80M 09/28/18 Boston
Catch CRISPR 2.0, RNA-Targeting Drugs & More At “Disruptors” on Oct. 17 09/26/18 Boston
CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy 09/17/18 San Diego
Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More 09/14/18 National
U.S. Court Affirms Broad’s CRISPR Patent; No Word of Berkeley Appeal 09/10/18 Boston
Sangamo 1st to Show Human Gene-Editing Results. Investors Say ‘Meh.’ 09/05/18 San Francisco
Inari Agriculture Harvests $40M to Ramp Up Gene Editing R&D 08/09/18 Boston
Bio Roundup: Drug Prices, CRISPR Caveats, Rubius IPO Pop & More 07/20/18 National
Bio Roundup: Not-BIO Party Foul, CRISPR Drama, Sickle Cell Updates 06/15/18 National
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells 06/11/18 National
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More 06/01/18 National
FDA Halts Plan for Vertex, CRISPR Therapeutics Sickle Cell Study 05/30/18 Boston
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M 05/14/18 Boston
Page 1 of 5 next page »